Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
News|Articles|October 15, 2019
Romaco Siebler and Huhtamaki Unveil the First Recyclable Strip Packaging
Author(s)Pharmaceutical Technology Editors
The companies will be presenting Push Packs at CPhI Worldwide on Nov. 5–7 in Frankfurt, Germany.
Advertisement
Romaco Siebler, a Germany-based process and packaging equipment supplier, and Huhtamaki, a food packaging company headquartered in Finland, announced they will be presenting Push Packs, the first recyclable strip packaging for pharmaceutical solids, at CPhI Worldwide on Nov. 5–7 in Frankfurt, Germany.
According to an Oct. 15, 2019 press release, the new packaging solution is made from recyclable polyolefin laminate which allows it to be recycled back into the material loop. The Push Packs are designed by processing the foil into four-side sealed strips with a push-through function using Romaco’s heat-sealing technology.
Additionally, Push Packs are thinner, lighter, and 60% cheaper than traditional blister packs.
The companies will be showcasing the Push Packs at Booth 111B53 at the event.
Source:
Advertisement
Related to this article
Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Advertisement
Advertisement